Staar Surgical Co STAA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if STAA is a good fit for your portfolio.
News
-
STAAR Surgical to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
-
STAAR Surgical Reports First Quarter 2024 Results
-
STAAR Surgical Announces Milestone Strategic Agreement in U.S. with IQ Laser Vision
-
STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel
-
STAAR Surgical to Report First Quarter Results on May 7, 2024
-
Dolby stock rises on upcoming move to S&P MidCap 400
Trading Information
- Previous Close Price
- $45.22
- Day Range
- $44.25–46.79
- 52-Week Range
- $26.66–58.35
- Bid/Ask
- $44.00 / $47.00
- Market Cap
- $2.25 Bil
- Volume/Avg
- 487,288 / 560,719
Key Statistics
- Price/Earnings (Normalized)
- 51.91
- Price/Sales
- 6.92
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.07%
Company Profile
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,115
- Website
- https://www.staar.com
Comparables
Valuation
Metric
|
STAA
|
RXST
|
SGHT
|
---|---|---|---|
Price/Earnings (Normalized) | 51.91 | — | — |
Price/Book Value | 5.70 | 11.21 | 3.77 |
Price/Sales | 6.92 | 17.48 | 4.99 |
Price/Cash Flow | 44.20 | — | — |
Price/Earnings
STAA
RXST
SGHT
Financial Strength
Metric
|
STAA
|
RXST
|
SGHT
|
---|---|---|---|
Quick Ratio | 4.99 | 8.02 | 12.22 |
Current Ratio | 5.84 | 9.20 | 13.01 |
Interest Coverage | — | −27.34 | −9.24 |
Quick Ratio
STAA
RXST
SGHT
Profitability
Metric
|
STAA
|
RXST
|
SGHT
|
---|---|---|---|
Return on Assets (Normalized) | 7.37% | −13.53% | −23.22% |
Return on Equity (Normalized) | 9.21% | −16.23% | −32.00% |
Return on Invested Capital (Normalized) | 7.12% | −17.05% | −22.54% |
Return on Assets
STAA
RXST
SGHT
Medical Instruments & Supplies Industry Comparables
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|---|
Intuitive Surgical Inc
ISRG
| Gdntphzv | Fgl | $155.4 Bil | |||
Becton Dickinson & Co
BDX
| Tpknvdpr | Rwtjt | $66.7 Bil | |||
Alcon Inc
ALC
| Ppgbgcx | Mnmrmt | $44.3 Bil | |||
ResMed Inc
RMD
| Kslbysrkx | Ycmzjh | $30.4 Bil | |||
Coloplast A/S ADR
CLPBY
| Zthhtwmvt | Tzstq | $28.3 Bil | |||
West Pharmaceutical Services Inc
WST
| Zwkzmqpds | Kbs | $24.1 Bil | |||
Hologic Inc
HOLX
| Djdscsm | Ckvmqb | $18.3 Bil | |||
Baxter International Inc
BAX
| Kflnjsyr | Hmrvzsc | $18.1 Bil | |||
The Cooper Companies Inc
COO
| Wxhgcwql | Chmsz | $17.9 Bil | |||
Teleflex Inc
TFX
| Fhvh | Xsj | $10.8 Bil |